Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is conducted in Asia. The aim of this observational study is to collect efficacy and safety data of biphasic insulin aspart (NovoMix® 30) in type 2 diabetes under normal clinical practice conditions.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BIAsp 30 users |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| biphasic insulin aspart 30 | Drug | Administered via an insulin injection device. Dosages varied according to individual patients' medical requirement as determined by their attending clinician |
| Measure | Description | Time Frame |
|---|---|---|
| HbA1c (glycosylated haemoglobin) |
| Measure | Description | Time Frame |
|---|---|---|
| FBG (Fasting Blood Glucose) | ||
| Quality of life assessed through the WHO-DTSQ (World Health Organization-Diabetes Treatment Satisfaction Questionnaire) | ||
| Incidence of adverse events |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients from hospitals or clinics diagnosed with type 2 diabetes mellitus
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Corporate Vice President for diabetes and devices | Novo Nordisk A/S | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Amman | 11844 | Jordan |
Not provided
| Label | URL |
|---|---|
| Clinical Trials at Novo Nordisk | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C557564 | insulin aspart, insulin aspart protamine drug combination 30:70 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Incidence of hypoglycaemic episodes |